{"id":"W4324136858","doi":"10.1200/jco.2023.41.6_suppl.tps287","title":"CAPItello-280: A phase III study of capivasertib and docetaxel versus placebo and docetaxel in metastatic castration-resistant prostate cancer.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Clinical endpoint; Oncology; Internal medicine; Enzalutamide; Taxane; Chemotherapy; Cancer; Clinical trial; Androgen receptor; Breast cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002360743,0.002070783,0.002584432,0.0007803772,0.0005245814,0.001420068,0.002031272,0.001700331,0.005845619],"category_scores_gemma":[0.001002263,0.0008629464,0.001850367,0.0008255112,0.001336305,0.0009648096,0.0003908342,0.004576562,0.001229663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001557947,"about_ca_system_score_gemma":0.00277251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002558163,"about_ca_topic_score_gemma":0.005348786,"domain_scores_codex":[0.9994351,0.0002655162,0.0000209636,0.0000967168,0.00007531465,0.0001063454],"domain_scores_gemma":[0.9989629,0.000146706,0.0001929787,0.00007458824,0.00007229608,0.0005505524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8151338,0.1005691,0.001512971,0.001258291,0.001750355,0.0001396492,0.0001674186,0.001612678,0.01924055,0.0004377936,0.004053434,0.05412397],"study_design_scores_gemma":[0.6830197,0.3082713,0.002756069,0.00005265884,0.0006362679,0.0001338423,0.00005088856,0.0009287984,0.002001154,0.0001400714,0.001976859,0.00003239675],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9792685,0.006918676,0.0008354152,0.0007034371,0.000424227,0.004745808,0.001877035,0.0002729303,0.004954023],"genre_scores_gemma":[0.9770077,0.005184876,0.002014036,0.001672469,0.0004908797,0.004647582,0.003560846,0.00006667698,0.005354862],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005845619,"threshold_uncertainty_score":0.01955551,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.250652462958183,"score_gpt":0.5513524197459858,"score_spread":0.3006999567878028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}